Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.210
-0.100 (-7.63%)
At close: Dec 5, 2025, 4:00 PM EST
1.240
+0.030 (2.47%)
After-hours: Dec 5, 2025, 7:49 PM EST
Pliant Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | 1.58 | 9.69 | 7.57 | 41.82 | |
| Revenue Growth (YoY) | - | - | -83.69% | 27.91% | -81.89% | -26.70% | |
| Gross Profit | - | - | 1.58 | 9.69 | 7.57 | 41.82 | |
| Selling, General & Admin | 54.75 | 59.06 | 57.93 | 39.95 | 27.56 | 17.27 | |
| Research & Development | 135.17 | 169.31 | 127.8 | 96.94 | 77.55 | 66.19 | |
| Operating Expenses | 189.92 | 228.37 | 185.73 | 136.89 | 105.11 | 83.46 | |
| Operating Income | -189.92 | -228.37 | -184.15 | -127.2 | -97.54 | -41.65 | |
| Interest Expense | -3.26 | -3.02 | -1.27 | -0.79 | - | - | |
| Interest & Investment Income | 13.87 | 21.09 | 24.08 | 4.67 | 0.27 | 0.11 | |
| Pretax Income | -175.5 | -210.3 | -161.34 | -123.32 | -97.26 | -41.53 | |
| Net Income | -175.5 | -210.3 | -161.34 | -123.32 | -97.26 | -41.53 | |
| Net Income to Common | -175.5 | -210.3 | -161.34 | -123.32 | -97.26 | -41.53 | |
| Shares Outstanding (Basic) | 61 | 61 | 59 | 42 | 36 | 21 | |
| Shares Outstanding (Diluted) | 61 | 61 | 59 | 42 | 36 | 21 | |
| Shares Change (YoY) | 1.52% | 3.10% | 39.75% | 17.21% | 67.94% | 1214.82% | |
| EPS (Basic) | -2.87 | -3.47 | -2.75 | -2.94 | -2.71 | -1.95 | |
| EPS (Diluted) | -2.87 | -3.47 | -2.75 | -2.94 | -2.71 | -1.95 | |
| Free Cash Flow | -158.79 | -159.35 | -117.28 | -96.39 | -77.4 | -38.8 | |
| Free Cash Flow Per Share | -2.59 | -2.63 | -2.00 | -2.29 | -2.16 | -1.82 | |
| Gross Margin | - | - | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | - | - | -11654.75% | -1313.37% | -1288.10% | -99.59% | |
| Profit Margin | - | - | -10211.14% | -1273.32% | -1284.51% | -99.32% | |
| Free Cash Flow Margin | - | - | -7422.91% | -995.26% | -1022.13% | -92.79% | |
| EBITDA | -188.13 | -226.24 | -182.3 | -125.38 | -96 | -40.34 | |
| EBITDA Margin | - | - | - | - | - | -96.46% | |
| D&A For EBITDA | 1.79 | 2.13 | 1.84 | 1.82 | 1.54 | 1.31 | |
| EBIT | -189.92 | -228.37 | -184.15 | -127.2 | -97.54 | -41.65 | |
| EBIT Margin | - | - | - | - | - | -99.59% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.